MarginsXMarginsX
Home › Markets › NYMXF

Nymox Pharmaceutical Corp (NYMXF)

NYMXF is quoted over the counter, not listed on an exchange. Nymox Pharmaceutical Corp files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · November 12, 2026
$0.0350
No trades since Nov 12, 2026; later closes repeat the last quote
1-year return
-65.0%
Market cap
$3.6M
Nano cap. From the Nov 12, 2026 last trade × 102M shares (20-F/A cover page, Dec 31, 2025)
P/E and P/S
Latest financials end 2024-12-31, over 15 months ago · Latest financials end 2024-12-31, over 15 months ago
On fiscal year to December 31, 2024 (20-F)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerNYMXF, quoted over the counter
SEC CIK0001018735
OTC Markets tierOTCID (price source, 2026-11-13)
SEC industry codeIn Vitro & In Vivo Diagnostic Substances
Business addressQuebec Canada, QC

Warning signs

Cash runway
3.8 months
$830K cash at December 31, 2021
Share count, 1 year
+7.9%
2024-12-31 to 2025-12-31 · +12.7% over 3 years
Going-concern doubt
Yes
20-F filed September 14, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Considering recent developments and the need for additional financing, there exists a material uncertainty that casts substantial doubt about the Corporation's ability to continue as a going concern."
20-F 2026-09-14
Cash and burn$830K cash; operating cash flow -$650K a quarter.Report 2024-12-31
Shares outstanding102,040,140 (2025-12-31); 94,540,140 a year earlier; 90,515,140 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorM&K CPAS, PLLC, The Woodlands, Texas, United StatesPCAOB Form AP 2026-09-18
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2024
2024-12-31
Not filed-$4.5M-$2.6MNot filedNo debt tagsNeeds four quarters20-F 2025-06-03
FY 2023
2023-12-31
$0-$8.8M-$4.1MNot filedNo debt tags$020-F 2025-06-03
FY 2022
2022-12-31
$0-$6.6M-$5.2MNot filedNo debt tags$020-F 2025-06-03
FY 2021
2021-12-31
$0-$12.5M-$9.8M$830KNo debt tags$020-F 2024-08-29
FY 2020
2020-12-31
$5K-$11.7M-$10.0M$3.6MNo debt tags$5K20-F 2023-05-02
FY 2019
2019-12-31
$116K-$13.2M-$7.4M$5.2MNo debt tags$116K20-F 2022-03-30
FY 2018
2018-12-31
$299K-$10.6M-$7.8M$7.9MNo debt tags$299K20-F 2021-03-29
FY 2017
2017-12-31
$224K-$13.4M-$6.2M$851KNo debt tags$224K20-F 2020-03-30

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentF-32022-03-29
Latest annual report20-F2026-09-14
Latest quarterly / interim6-K2026-08-31

Source: SEC EDGAR submissions feed, 408 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier